FOXM1 and malignant colon neoplasm: Sung Song et al’s study demonstrated that FOXM1 can transcriptionally activate PRX3 and the stem cell marker CD133, maintaining the stemness in colon cancer stem cells (CSCs) by promoting mitochondrial function [31].